Loading…
Clinitech Laboratory (BSE 544220)₹30.000.00%Healthcare Service Provider
At the end of the Mar 2026 quarter, Clinitech Laboratory's shareholders were: promoters 64.22%, FIIs 0.32%, public 35.46%. Promoter holding is up 1.79 percentage points from 62.43% a quarter earlier. 0.00% of promoter shares were pledged. It had 298 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|
| Promoters | 61.59% | 61.59% | 62.43% | 64.22% |
| FIIs | 0.32% | 0.32% | 0.32% | 0.32% |
| Public | 38.09% | 38.09% | 37.25% | 35.46% |
| Promoter shares pledged | — | — | — | 0.00% |
| Number of shareholders | 347 | 304 | 304 | 298 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Jagdish Umakant Nayak | Promoter | 31.69% | — |
| Jyoti Jagdish Nayak | Promoter | 29.59% | — |
| Santosh Gopalkrishna Kudva | Public | 5.88% | — |
| Krisha V Talreja | Public | 3.09% | — |
| Siddhesh Anant Nayak | Promoter | 2.42% | — |
| Ajit Sakharam Kandar | Public | 2.25% | — |
| Shirish Nanubhai Patel | Public | 1.57% | — |
| Siddhesh Nayak | Promoter | 0.53% | — |
Promoters held 64.22% of Clinitech Laboratory at the end of the Mar 2026 quarter.
In the Mar 2026 quarter, foreign institutional investors (FIIs) held 0.32% (unchanged at 0.32% a quarter earlier) and domestic institutions (DIIs) held no reported stake.
No. The Mar 2026 filing shows no pledged promoter shares.
Clinitech Laboratory had 298 shareholders at the end of the Mar 2026 quarter.
Santosh Gopalkrishna Kudva (Public) held 5.88% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.